Scientists Find Enzyme That Triggers Cancer's Most Chaotic DNA Destruction
Researchers identify N4BP2, the enzyme behind chromothripsis - a genetic catastrophe that helps one in four cancers rapidly evolve and resist treatment.
20 articles
Researchers identify N4BP2, the enzyme behind chromothripsis - a genetic catastrophe that helps one in four cancers rapidly evolve and resist treatment.
When the DNA-repair gene EXO1 is overproduced, it damages DNA instead of fixing itβexposing a hidden vulnerability in multiple cancers.
Researchers discovered how to restore tumor-killing power in worn-out immune cells by switching off just two genes.
A protein called HOXD13 drives skin cancer growth and shields tumors from immune cells β disabling it could unlock powerful new treatments.
A small molecule called UNI418 shuts down cancer cells' DNA repair machinery, making drug-resistant tumors vulnerable to treatment again.
Disabling the NFIL3 protein prevents CAR T cell exhaustion, boosting tumor-fighting power in animal models of hard-to-treat cancers.
When tumors hide from killer T cells, they accidentally expose themselves to helper T cells that trigger a lethal iron-driven cell death process.
A newly identified molecule called SLAMF6 exhausts cancer-fighting T cells from within β and blocking it may revive failed immunotherapies.
Key biotech companies developing T cell engager therapies that redirect immune cells to fight cancer more effectively.
Scientists found drugs that kill senescent 'zombie cells' by blocking their key survival protein, shrinking tumors in mice.
MYC protein doesn't just fuel tumor growth β it also repairs DNA damage from chemotherapy, revealing a key resistance mechanism.
New research reveals senescent cells have both harmful and protective roles, pushing anti-aging science toward targeted removal strategies.
New research reveals how tumors reprogram neutrophils to produce CCL3, turning immune defenders into cancer allies.
A new imaging breakthrough reveals how immune cells target cancer with nanoscale precision, opening doors for better immunotherapy.
Revolutionary CRISPR technique bypasses lab manufacturing by programming immune cells to fight cancer directly in the body.
A new DNA-based treatment blocks the PCSK9 protein, cutting LDL cholesterol by nearly 50% while avoiding common statin side effects.
Scientists discover nerve fibers create a self-sustaining loop that accelerates pancreatic cancer development before tumors even form.
Researchers found 260,000 cancer-specific RNAs that act as molecular fingerprints and can be detected through simple blood tests.
Northwestern researchers dramatically boosted cancer vaccine effectiveness by simply repositioning one protein fragment on their nanovaccine.
Chinese researchers developed a breakthrough method to mass-produce powerful immune cells that hunt and destroy cancer tumors.